Did not become law. It stopped in the House of Representatives's Drug Policy Committee on March 3, 2020. The 2020 session has ended.
2020 Regular Session
House Bill 1502
Opiod drugs; prescriber shall discuss with patient before prescribing, the risks of the drugs and available alternatives.
What it does
The synopsis the Legislature published with the bill.
AN ACT TO AMEND SECTION 41-29-137, MISSISSIPPI CODE OF 1972, TO REQUIRE THE PRESCRIBER OF A SCHEDULE II CONTROLLED SUBSTANCE OR ANY OTHER OPIOID DRUG, BEFORE ISSUING THE INITIAL PRESCRIPTION IN A COURSE OF TREATMENT FOR ACUTE OR CHRONIC PAIN AND AGAIN BEFORE ISSUING THE THIRD PRESCRIPTION OF THE COURSE OF TREATMENT, TO DISCUSS WITH THE PATIENT THE RISKS ASSOCIATED WITH THE DRUG BEING PRESCRIBED AND ALTERNATIVE TREATMENTS THAT MAY BE AVAILABLE; AND FOR RELATED PURPOSES.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
Its course
February 17 to March 3, 2020, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action2 actions on 2 days
In the House of RepresentativesFeb 17 to Mar 3 · stopped15 days
Drug PolicyFeb 17 to Mar 3 · stopped15 days
Text
Each version as the Legislature printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislature published it is below.
In the House of Representatives Feb 17 – Mar 3
- Feb 17Referred to the House committee on Drug Policy
- Mar 3Died in committee in the House
All 2 actions, as published
- Feb 17Referred To Drug PolicyHouse of Representatives
- Mar 3Died In CommitteeHouse of Representatives